505 related articles for article (PubMed ID: 30594453)
1. Synthesis and evaluation of Re/
Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a
Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor targeting with hydrophilic [
Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
[TBL] [Abstract][Full Text] [Related]
4. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
5. p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the
H A Kankanamalage P; Hoerres R; Ho KV; Anderson CJ; Gallazzi F; Hennkens HM
Nucl Med Biol; 2022; 108-109():1-9. PubMed ID: 35144046
[TBL] [Abstract][Full Text] [Related]
6. Clickable, hydrophilic ligand for fac-[M(I)(CO)3](+) (M = Re/(99m)Tc) applied in an S-functionalized α-MSH peptide.
Kasten BB; Ma X; Liu H; Hayes TR; Barnes CL; Qi S; Cheng K; Bottorff SC; Slocumb WS; Wang J; Cheng Z; Benny PD
Bioconjug Chem; 2014 Mar; 25(3):579-92. PubMed ID: 24568284
[TBL] [Abstract][Full Text] [Related]
7. Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.
Jiang H; Kasten BB; Liu H; Qi S; Liu Y; Tian M; Barnes CL; Zhang H; Cheng Z; Benny PD
Bioconjug Chem; 2012 Nov; 23(11):2300-12. PubMed ID: 23110503
[TBL] [Abstract][Full Text] [Related]
8. Development and Preclinical Evaluation of
Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
[TBL] [Abstract][Full Text] [Related]
9. Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.
Kasten BB; Ma X; Cheng K; Bu L; Slocumb WS; Hayes TR; Trabue S; Cheng Z; Benny PD
Bioconjug Chem; 2016 Jan; 27(1):130-42. PubMed ID: 26603218
[TBL] [Abstract][Full Text] [Related]
10. Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re,
Wang J; Makris G; Kuchuk M; Radford L; Gallazzi F; Lewis MR; Jurisson SS; Hennkens HM
Nucl Med Biol; 2021; 94-95():46-52. PubMed ID: 33515899
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
12. Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.
Wadas TJ; Eiblmaier M; Zheleznyak A; Sherman CD; Ferdani R; Liang K; Achilefu S; Anderson CJ
J Nucl Med; 2008 Nov; 49(11):1819-27. PubMed ID: 18927338
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.
De K; Banerjee I; Misra M
Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
[TBL] [Abstract][Full Text] [Related]
15. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.
Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A
Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465
[TBL] [Abstract][Full Text] [Related]
16. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization, and In Vitro Evaluation of New (99m)Tc/Re(V)-Cyclized Octreotide Analogues: An Experimental and Computational Approach.
Li Y; Ma L; Gaddam V; Gallazzi F; Hennkens HM; Harmata M; Lewis MR; Deakyne CA; Jurisson SS
Inorg Chem; 2016 Feb; 55(3):1124-33. PubMed ID: 26789775
[TBL] [Abstract][Full Text] [Related]
18. Tricarbonyl (99m)Tc(i) and Re(i)-thiosemicarbazone complexes: synthesis, characterization and biological evaluation for targeting bacterial infection.
Nayak DK; Baishya R; Natarajan R; Sen T; Debnath MC
Dalton Trans; 2015 Sep; 44(36):16136-48. PubMed ID: 26289802
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and comparative in vivo evaluation of
Vats K; Satpati D; Sharma R; Sarma HD; Banerjee S
Chem Biol Drug Des; 2017 Mar; 89(3):371-378. PubMed ID: 27561428
[TBL] [Abstract][Full Text] [Related]
20. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]